« Back to Record
Citation APA

Hoeper, M. M., Klinger, J. J., Benza, R. L., Simonneau, G., Langleben, D., Naeije, R., & Corris, P. (2017). Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors. Respiratory medicine, 122, S18-S22. doi:10.1016/j.rmed.2016.11.001


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247797

Hoeper, M. M., Klinger, J. J., Benza, R. L., Simonneau, G., Langleben, D., Naeije, R., & Corris, P. (2017). Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors. Respiratory medicine, 122, S18-S22. doi:10.1016/j.rmed.2016.11.001